ArticleScientific reports2026
Novel approach to early prediction of alzheimer's disease progression using integrated deep regulatory genetic neural network and optimized deep belief networks.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To enhance the prediction progression of Alzheimer's Disease is very excavating process. PROBLEM STATEMENT: It is often very difficult to implement in the chronic neurodegenerative disease-related preprocessed gene expression data. Especially, Alzheimer's Disease (AD) prediction is a very crucial process in AD metadata diagnosis. Novelty: To explore this challenging prediction process in brain disease prediction, this research presents a proposed deep learning model, namely the Integrated Deep Regulatory Genetic Neural Network and Optimised Deep Belief Networks (IDRODN). This integration increases the affluence of prediction progression from genomic data. These prediction systems help identify early AD.
methodThis research utilizes the IDRODN, which can predict and confine each network's neurons and hidden layers against the benchmark dataset of Alzheimer's gene expression and uncertainty to predict Alzheimer's Disease. KEY
resultsThe comparative analysis on data from the Alzheimer's disease gene expression data Initiative database has achieved an accuracy of 98.3%. In addition, it has achieved a high F1 score of 0.986 for predicting different stages from Gene expression data. IMPLICATIONS: This shows the most accurate technique for predicting Alzheimer's Disease (AD) using the prognostic IDRODN model.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.